Romskaug 2017.
Trial name or title | Cooperation between geriatricians and general practitioners for improved pharmacotherapy in home‐dwelling elderly people receiving polypharmacy – the COOP Study |
Methods | Cluster‐randomised, single‐blind, controlled trial |
Participants | Quote: “The patients must be 70 years or older, use at least seven different medications and have their medications administered by the home nursing service” |
Interventions | Quote: “The intervention consists of three main parts: (1) clinical geriatric assessment of the patient, combined with a thorough review of their medications; (2) a meeting between the geriatrician and general practitioner, where the two physicians combine their competence and knowledge and discuss the drug list systematically; (3) clinical follow‐up, depending on the medication changes that have been done” |
Outcomes | Quote: “The primary outcome measure is health‐related quality of life according to the 15D instrument. Secondary outcome measures include physical and cognitive functioning, medication appropriateness (MAI), falls, carer burden, use of health services (hospital or nursing home admissions, use of home nursing services) and mortality” |
Starting date | March 2015 |
Contact information | Rita Romskaug Department of Geriatric medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway ritulf@gmail.com |
Notes |
NCT02379455 Intervention phase ongoing |